NCT04343573
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 2
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: up to 99 Years (Child, Adult, Older Adult)
Location of Metastases: Leptomeningeal Disease
Additional Notes: Patients must be candidates for radiation therapy for the treatment of leptomeningeal metastases
Exclusions: 
https://ClinicalTrials.gov/show/NCT04343573